Association of Osteoprotegerin With Human Abdominal Aortic Aneurysm Progression

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation

• Publication date

  2005-06-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.104.464727PMID 15939823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteoprotegerin and Osteopontin Are Expressed at High Concentrations Within Symptomatic Carotid Atherosclerosis

  2004cited by this paper
• Angiotensin II-mediated development of vascular diseases.

  2004cited by this paper
• Regulation of osteoclast differentiation and function by receptor activator of NFκB ligand and osteoprotegerin

  2004cited by this paper
• Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease

  2004cited by this paper
• C-Reactive Protein Levels and the Expansion of Screen-Detected Abdominal Aortic Aneurysms in Men

  2004cited by this paper
• Abnormal Extracellular Matrix Protein Transport Associated With Increased Apoptosis of Vascular Smooth Muscle Cells in Marfan Syndrome and Bicuspid Aortic Valve Thoracic Aortic Aneurysm

  2003cited by this paper
• Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.

  2003cited by this paper
• Current concepts in the pathogenesis of abdominal aortic aneurysm.

  2003cited by this paper
• Urokinase-Type Plasminogen Activator Plays a Critical Role in Angiotensin II–Induced Abdominal Aortic Aneurysm

  2003cited by this paper
• Osteoprotegerin differentially regulates protease expression in osteoclast cultures.

  2002cited by this paper
• Serum Osteoprotegerin Levels Are Associated With the Presence and Severity of Coronary Artery Disease

  2002cited by this paper
• Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.

  2002cited by this paper
• PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways

  2002cited by this paper
• Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin

  2002cited by this paper
• Increased local angiotensin II formation in aneurysmal aorta.

  2002cited by this paper
• Mortality rates from ruptured abdominal aortic aneurysms in England

  2001cited by this paper
• Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.

  2001cited by this paper
• Initial Results of Ultrasound Screening for Aneurysm of the Abdominal Aorta in Western Australia: Relevance for Endoluminal Treatment of Aneurysm Disease

  2001cited by this paper
• Osteoprotegerin, a Crucial Regulator of Bone Metabolism, Also Regulates B Cell Development and Function1

  2001cited by this paper
• Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells*

  2000cited by this paper
• Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells.

  2000cited by this paper
• Arterial flow conditions downregulate thrombomodulin on saphenous vein endothelium.

  1999cited by this paper
• A novel molecular mechanism modulating osteoclast differentiation and function.

  1999cited by this paper
• Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.

  1997cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• Relationship of age, gender, race, and body size to infrarenal aortic diameter. The Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Investigators.

  1997cited by this paper
• Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms.

  1996cited by this paper
• Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β

  1996cited by this paper
• Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta.

  1996cited by this paper
• Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.

  1994cited by this paper
• Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells.

  1990cited by this paper

• Osteoprotegerin is associated with reduced risk of abdominal aortic aneurysm and the role of vascular calcification: insights from Mendelian randomization approach.

  2026cites this paper
• Thoracic aortic aneurysm and dissection: Similarities, differences and pharmacotherapy.

  2026cites this paper
• On the path to personalized cardiology: prospects of precise assessment of cardiovascular risks and predictive-prognostic diagnostics

  2025cites this paper
• Aortic aneurysm: Correlations with phenotypes associated with connective tissue dysplasia.

  2024cites this paper
• Current Prognostic Biomarkers for Abdominal Aortic Aneurysm: A Comprehensive Scoping Review of the Literature

  2024cites this paper
• The role of the osteoprotegerin/RANKL/RANK axis and osteopontin in acute coronary syndrome.

  2024cites this paper
• Osteoprotegerin Is Essential for the Development of Endothelial Dysfunction Induced by Angiotensin II in Mice

  2024influential citation
• Association of serum vitamin D with diagnosis and growth of abdominal aortic aneurysm

  2024cites this paper
• Tumor Necrosis Factor Family Members and Myocardial Ischemia-Reperfusion Injury: State of the Art and Therapeutic Implications

  2023cites this paper
• Targeted drug delivery of magnetic microbubble for abdominal aortic aneurysm: an in silico study

  2022cites this paper
• Plasma complement component C2: a potential biomarker for predicting abdominal aortic aneurysm related complications

  2022cites this paper
• Osteoprotegerin Deficiency and Aneurysm Formation: Case Report of Iliac Artery Aneurysms in Juvenile Paget's Disease

  2022cites this paper
• Peptide Amphiphile Supramolecular Nanofibers Designed to Target Abdominal Aortic Aneurysms.

  2022cites this paper
• Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E–deficient mice

  2021influential citation
• OPG/TRAIL ratio as a predictive biomarker of mortality in patients with type A acute aortic dissection

  2021cites this paper
• Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases

  2021cites this paper
• The role of vascular smooth muscle cells in the development of aortic aneurysms and dissections

  2021cites this paper
• Imaging Biological Pathways in Abdominal Aortic Aneurysms Using Positron Emission Tomography.

  2021cites this paper
• Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an αVβ3/FAK dependent YAP pathway.

  2020cites this paper
• Vitamin D deficiency promotes large rupture-prone abdominal aortic aneurysms and cholecalciferol supplementation limits progression of aneurysms in a mouse model

  2020cites this paper
• BIOMARKERS FOR ANEURYSM GROWTH AND RUPTURE

  2020cites this paper
• Osteoprotegerin Prevents Intracranial Aneurysm Progression by Promoting Collagen Biosynthesis and Vascular Smooth Muscle Cell Proliferation

  2020cites this paper
• The role of osteoprotegerin in the development, progression and management of abdominal aortic aneurysms

  2020cites this paper
• Single-Cell Transcriptomic Profiling of Vascular Smooth Muscle Cell Phenotype Modulation in Marfan Syndrome Aortic Aneurysm

  2020cites this paper
• Disruption of Osteoprotegerin has complex effects on medial destruction and adventitial fibrosis during mouse abdominal aortic aneurysm formation

  2020cites this paper
• MiR-29a-3p down-regulation of MMP-2 expression affects proliferation and apoptosis of smooth muscle cells in rats with abdominal aortic aneurysm

  2020cites this paper
• Biomarkers in Vascular Disease

  2020cites this paper
• miR-145 improves metabolic inflammatory disease through multiple pathways

  2019cites this paper
• Inflammatory cell infiltrates, hypoxia, vascularization, pentraxin 3 and osteoprotegerin in abdominal aortic aneurysms – A quantitative histological study

  2019cites this paper
• The Role of Osteoprotegerin and Its Ligands in Vascular Function

  2019cites this paper
• Construction of lncRNA-miRNA-mRNA networks reveals functional lncRNAs in abdominal aortic aneurysm

  2018cites this paper
• Functional promoter −1816C>G variant of RANKL predicts risk and prognosis of lone atrial fibrillation

  2018cites this paper
• Effects of osteoprotegerin/TNFRSF11B in two models of abdominal aortic aneurysms

  2018cites this paper
• The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox

  2018cites this paper
• Chinese Herbal Medicine as a Potential Treatment of Abdominal Aortic Aneurysm

  2018cites this paper
• Systematic Review of Circulating, Biomechanical, and Genetic Markers for the Prediction of Abdominal Aortic Aneurysm Growth and Rupture

  2018cites this paper
• Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm

  2017cites this paper
• TSG-6 is highly expressed in human abdominal aortic aneurysms.

  2017cites this paper
• OSTEOPROTEGERIN AS A NEW POSSIBLE PLAYER IN MITRAL VALVE PROLAPSE WITH SEVERE REGURGITATION: FROM IN VITRO TO HUMAN STUDIES

  2017cites this paper
• Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial

  2017cites this paper
• Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II–Induced Aortic Aneurysm and Atherosclerosis

  2017cites this paper
• The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases

  2017cites this paper
• Inositol in the MAnaGemENt of abdominal aortic aneurysm (IMAGEN): study protocol for a randomised controlled trial

  2017cites this paper
• Circulating biomarkers are not associated with endoleaks after endovascular repair of abdominal aortic aneurysms.

  2017cites this paper
• Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis

  2017cites this paper
• Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II–Infused Apolipoprotein E–Deficient Mouse

  2016cites this paper
• Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

  2016cites this paper
• Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition.

  2016cites this paper
• Surrogate Markers of Abdominal Aortic Aneurysm Progression

  2016cites this paper
• Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms

  2016cites this paper
• RANKL promotes osteoblastic activity in vascular smooth muscle cells by upregulating endothelial BMP-2 release.

  2016cites this paper
• Tumor Necrosis Factor Alpha 308 Genepolymorphism and Serum Osteoprotogerin Inarteriovenous Fistula Dysfunction Inhemodialysis Patients

  2016cites this paper
• Osteoprotegerin in Turner syndrome – relationship to aortic diameter

  2015cites this paper
• Abdominal aortic aneurysm: novel mechanisms and therapies

  2015cites this paper
• Combining detection of Notch1 and tumor necrosis factor-α converting enzyme is a reliable biomarker for the diagnosis of abdominal aortic aneurysms.

  2015cites this paper
• Abdominal aortic aneurysms and diabetes mellitus.

  2015cites this paper
• Omega 3 Polyunsaturated Fatty Acids Suppress the Development of Aortic Aneurysms Through the Inhibition of Macrophage-Mediated Inflammation.

  2015cites this paper
• Nutritional Evaluation as Influenced by Cooking of Some Saudi Traditional Dishes

  2015cites this paper
• Knockout Mouse − in the Apolipoprotein E Induced Aortic Dilatation and Rupture − Osteoprotegerin Deficiency Limits Angiotensin II

  2014cites this paper
• The differential expression of microrna in abdominal aortic aneurysms

  2014cites this paper
• Osteoprotegerin is associated with subclinical left ventricular systolic dysfunction in diabetic hypertensive patients: a speckle tracking study.

  2014cites this paper
• Inflammatory plasma biomarkers of abdominal aortic aneurysms

  2014influential citation
• Novel Biomarkers of Abdominal Aortic Aneurysm Disease: Identifying Gaps and Dispelling Misperceptions

  2014cites this paper
• Meta‐analysis and meta‐regression analysis of biomarkers for abdominal aortic aneurysm

  2014cites this paper
• Osteopontin and Osteoprotegerin as Potential Biomarkers in Abdominal Aortic Aneurysm before and after Treatment

  2014cites this paper
• Targets for medical therapy to limit abdominal aortic aneurysm progression.

  2014cites this paper
• Osteoprotegerin is Secreted Into the Coronary Circulation: A Possible Association with the Renin-Angiotensin System and Cardiac Hypertrophy

  2014cites this paper
• Inflammatory mediators after endovascular aortic aneurysm repair.

  2014cites this paper
• Osteoprotegerin Deficiency Limits Angiotensin II–Induced Aortic Dilatation and Rupture in the Apolipoprotein E–Knockout Mouse

  2014influential citation
• Urocortin 2 is associated with abdominal aortic aneurysm and mediates anti-proliferative effects on vascular smooth muscle cells via corticotrophin releasing factor receptor 2.

  2014cites this paper
• ASSOCIATION BETWEEN DRUG RESISTANT HYPERTENSION AND INCREASED OSTEOPROTEGERIN LEVELS IN HYPERTENSIVE MALE PATIENTS WITH NON OBSTRUCTIVE SLEEP APNEA

  2014cites this paper
• ASSOCIATION BETWEEN DRUG RESISTANT HYPERTENSION AND INCREASED OSTEOPROTEGERIN LEVELS IN HYPERTENSIVE MALE PATIENTS WITH NON OBSTRUCTIVE SLEEP APNEA

  2014cites this paper
• Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.

  2013cites this paper
• Association of post-cardioversion transcardiac concentration gradient of soluble tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL) and inflammatory biomarkers to atrial fibrillation recurrence.

  2013cites this paper
• Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation.

  2013cites this paper
• Relationship of Osteoprotegerin Level and Chronic Kidney Disease-Metabolic Bone Disease ( CKD-MBD )

  2013cites this paper
• L’ostéoprotégérine, nouvel acteur dans l’angiogenèse : Rôle dans la formation de nouveaux vaisseaux et mécanisme d’action

  2013cites this paper
• in vitro and in vivo Osteoprotegerin increases leukocyte adhesion to endothelial cells both

  2013cites this paper
• Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo

  2012cites this paper
• Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms.

  2012cites this paper
• Medical therapy of thoracic aortic aneurysms.

  2012cites this paper
• Osteoprotegerin Is Associated With Aneurysm Diameter and Proteolysis in Abdominal Aortic Aneurysm Disease

  2012influential citation
• Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis

  2012cites this paper
• OPG/RANK/RANKL Axis in Stabilization of Spontaneously Restored Sinus Rhythm in Permanent Atrial Fibrillation Patients after Mitral Valve Surgery

  2012cites this paper
• Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes

  2012cites this paper
• Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levels.

  2012cites this paper
• Characterization of non-collagenous extracellular matrix proteins in cardiac and aortic valve remodelling

  2012cites this paper
• No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells.

  2012cites this paper
• Genes and abdominal aortic aneurysm.

  2011cites this paper
• TNFRSF 11 B ( tumor necrosis factor receptor superfamily , member 11 b )

  2011cites this paper
• Osteoprotegerin and diabetes-associated pathologies.

  2011cites this paper
• Contemporary Reviews in Cardiovascular Medicine Medical Therapy of Thoracic Aortic Aneurysms

  2011cites this paper
• Discrepancies in abdominal aortic aneurysm expressions and repair

  2011cites this paper
• Mögliche Biomarker des abdominellen Aortenaneurysmas - Matrix Metalloproteinasen-2/9 und Osteoprotegerin

  2011influential citation
• Gènes et anévrysmes de l’aorte abdominale

  2011cites this paper
• Neuropsychiatric Symptoms in Patients with Aortic Aneurysms

  2011cites this paper
• Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation.

  2011cites this paper
• Relevance of urocortins to cardiovascular disease.

  2011cites this paper
• The role of the osteoprotegerin/RANKL/RANK system in diabetic vascular disease.

  2011cites this paper
• Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop.

  2011cites this paper